These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29872453)

  • 41. Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature.
    Pericleous M; Toumpanakis C; Lumgair H; Caplin ME; Morgan-Rowe L; Clark I; Luong TV
    Case Rep Oncol; 2012 May; 5(2):313-9. PubMed ID: 22740822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a Distinct Entity.
    Gaikwad V; Patkar S; Barreto SG; Sirohi B; Goel M; Shrikhande SV
    Indian J Surg; 2017 Jun; 79(3):226-233. PubMed ID: 28659676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
    Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
    J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats.
    Fossmark R; Zhao CM; Martinsen TC; Kawase S; Chen D; Waldum HL
    APMIS; 2005 Jun; 113(6):436-49. PubMed ID: 15996161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroendocrine gastrointestinal tumours.
    Oberg K
    Ann Oncol; 1996 Jul; 7(5):453-63. PubMed ID: 8839899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of class III beta-tubulin in neuroendocrine tumours of gastrointestinal tract.
    Jirásek T; Mandys V; Viklický V
    Folia Histochem Cytobiol; 2002; 40(3):305-10. PubMed ID: 12219841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.
    Frilling A; Smith G; Clift AK; Martin J
    Dig Liver Dis; 2014 Nov; 46(11):1038-42. PubMed ID: 25086997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.
    Reubi JC; Waser B
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):781-93. PubMed ID: 12707737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New treatment strategies in advanced neuroendocrine tumours.
    Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G
    Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis.
    Koten JW; Neijt JP; Zonnenberg BA; Den Otter W
    Anticancer Res; 1993; 13(4):1179-82. PubMed ID: 8352541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples.
    Speights VO; Cohen MK; Riggs MW; Coffield KS; Keegan G; Arber DA
    Br J Urol; 1997 Aug; 80(2):281-6. PubMed ID: 9284203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
    Roberts J; Gonzalez RS; Revetta F; Shi C
    Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paraneoplastic syndromes secondary to neuroendocrine tumours.
    Kaltsas G; Androulakis II; de Herder WW; Grossman AB
    Endocr Relat Cancer; 2010 Sep; 17(3):R173-93. PubMed ID: 20530594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The migrating cancer stem cells model--a conceptual explanation of malignant tumour progression.
    Jung A; Brabletz T; Kirchner T
    Ernst Schering Found Symp Proc; 2006; (5):109-24. PubMed ID: 17939298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours.
    Armeni E; Alexandraki KI; Roncaroli F; Grossman AB
    Arch Med Res; 2023 Dec; 54(8):102841. PubMed ID: 37394342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.
    Qvigstad G; Qvigstad T; Westre B; Sandvik AK; Brenna E; Waldum HL
    APMIS; 2002 Feb; 110(2):132-9. PubMed ID: 12064868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.